With winter here, South Africa faces a rise in flu cases. This article explores the influenza virus, its symptoms, and ...

Moderna this week announced positive data from a phase 3 trial of its messenger RNA vaccine against seasonal influenza, which ...

The trial readout comes at a time of turbulence in the vaccine sector after RFK Jr replaced every member of the ACIP panel.

Moderna Inc. said Monday its experimental flu shot showed positive results in a late-stage trial.   In a Phase 3 study, the ...

In adults 50 and older, Moderna’s flu shot was more than 26% better than an unspecified commercial vaccine. In May, the ...

At 21-42 days post-vaccination, the geometric mean haemagglutination inhibition titres were 32% higher for H1N1, 55% for H3N2, and 39% for B strains among recipients of the high-dose vaccine than ...

including A/H1N1, A/H3N2 and the B/Victoria lineages. Moderna said the vaccine's benefit was consistent across different age groups, people with various risk factors and previous vaccination status ...

The CDC's vaccine advisory committee voted to recommend annual flu vaccines but against flu shots containing the preservative ...

A CDC advisory panel voted 5–1 to recommend only flu vaccines without the preservative thimerosal, a mercury-containing ...

ATLANTA — U.S. Health Secretary Robert F. Kennedy Jr.'s new vaccine advisory committee backed another option to protect ...

Pigs could play a key role in ending the flu as we know it. That’s the message behind new research testing a computer-designed vaccine that protects swine from flu—and may one day do the same ...

New research results from mouse and swine studies, describe a vaccine that protects against H1N1 swine flu and can also protect against human and bird influenza variants.  Post-experiment ...